Home › NDC Lookup › RxCUI directory › RxCUI 310982

Imiquimod 50 MG/ML Topical Cream — RxCUI 310982

RxNorm drug concept · Semantic clinical drug
RxCUI 310982 Semantic clinical drug · SCD ● Current RxNorm concept 7 FDA products 8 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI310982
Official nameImiquimod 50 MG/ML Topical Cream
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asimiquimod 5 % Topical Cream
FDA products mapped7
Package NDCs mapped8
Reported Medicaid activity (SDUD)91,671 prescriptions · 51 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Imiquimod Topical: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • Yes — and that's actually expected. Redness, flaking, and even some crusting or sores at the treatment site are a normal sign that the cream is doing its job. For actinic keratoses...
  • How long does it take for imiquimod to work, and will the treated area look worse before it gets better?
  • It's important to stick to the schedule your doctor prescribed — not more often. Using it more frequently than directed can make skin reactions much more severe without making trea...
  • Can I use imiquimod every day to speed things up?
📖 Read our full Imiquimod Topical guide →

🕸️ Concept Web — How Imiquimod 50 MG/ML Topical Cream Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Imiquimod 50 MG/ML Topical Cream RxCUI 310982

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 1

    The active substance itself — no strength, form, or brand attached yet.

    • Imiquimod 59943
  2. Dose forms 4

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Imiquimod Topical Cream 378638
    • Imiquimod Topical Product 1160686
    • Topical Cream 316982
    • Topical Product 1151122
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Imiquimod 50 MG/ML 346058

Showing up to 8 concepts per family — 6 of 6 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Imiquimod 50 MG/ML SCDC · 346058
  • Imiquimod Topical Cream SCDF · 378638
  • Imiquimod Topical Product SCDG · 1160686

📦 FDA Products & Package NDCs

7 products · 8 package NDCs
8 package NDCs map to RxCUI 310982 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
45802-0368-53 12 PACKET in 1 CARTON (45802-368-53) / .25 g in 1 PACKET Imiquimod Padagis Israel Pharmaceuticals Ltd 2012-07-12
45802-0368-62 24 PACKET in 1 CARTON (45802-368-62) / .25 g in 1 PACKET Imiquimod Padagis Israel Pharmaceuticals Ltd 2010-11-09
51672-4145-06 24 PACKET in 1 CARTON (51672-4145-6) / .25 g in 1 PACKET (5... Imiquimod Sun Pharmaceutical Industries, Inc. 2011-04-15
68462-0536-70 24 PACKET in 1 CARTON (68462-536-70) / .25 g in 1 PACKET (6... Imiquimod Glenmark Pharmaceuticals Inc., USA 2012-03-06
71335-2725-01 24 PACKET in 1 CARTON (71335-2725-1) / .25 g in 1 PACKET Imiquimod Bryant Ranch Prepack 2025-07-30
71335-3000-01 24 PACKET in 1 CARTON (71335-3000-1) / .25 g in 1 PACKET Imiquimod Bryant Ranch Prepack 2025-11-05
72162-2332-02 24 PACKET in 1 CARTON (72162-2332-2) / .25 g in 1 PACKET Imiquimod Bryant Ranch Prepack 2024-06-18
72189-0084-24 .25 g in 1 PACKET (72189-084-24) IMIQUIMOD DIRECT RX 2020-03-23
Observed labelers: Bryant Ranch Prepack (3) · Padagis Israel Pharmaceuticals Ltd (2) · DIRECT RX (1) · Glenmark Pharmaceuticals Inc., USA (1) · Sun Pharmaceutical Industries, Inc. (1) — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.